Repligen

RGEN

RGEN
Repligen Stock Quote
$68.99 $1.96 0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:37 p.m. View Interactive RGEN Charts

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

News & Analysis: Repligen

The Fool has written over 100 articles on Repligen.

All

Market Moves

Earnings








3 Growth Stocks for in-the-Know Investors

An underrated biotech, a boring industrials play, and an intriguing cloud company: Here's why these growth stocks deserve your attention.




Interactive Chart